News 'Transformational' pill for endometriosis gets NHS nod Around 1,000 women in England a year with endometriosis will soon have access to the first daily oral therapy, Gedeon Richter's Ryeqo, via the NHS.
News Gedeon Richter gets NICE nod for uterine fibroids drug Ryeqo Around 4,500 women in the UK will be eligible for treatment with Gedeon Richter's once-daily oral therapy Ryeqo, after NICE backed the GnRH antagonist to treat heavy menstrual bleeding asso
News Allergan and Gedeon Richter set to expand use of bipolar dru... Companies want Vraylar as option bipolar depression
News Drug price controversies hit pharma's reputation Patient groups slam pharma over drug costs in latest survey.
News Allergan/Gedeon Richter's uterine fibroids drug succeeds in ... Allergan and Gedeon Richter's uterine fibroid treatment ulipristal acetate, has succeeded in a phase 3 trial ahead of a planned US filing next year.
Digital Post-ASCO 25: Pamela Tenaerts on CGTs and digital-first long... In a post-ASCO 2025 conversation, pharmaphorum web editor Nicole Raleigh spoke with Dr Pamela Tenaerts, chief medical officer at Medable.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face